Drawing for AGEBIOTICS

USPTO serial 79405160

AGEBIOTICS

Reviewed by CopyMark Law Group

Status 661
Filing date
Status date
Registration date
—
Examiner
BATT, JAIME L
Law office
TMO LAW OFFICE 125

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AGEBIOTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erica W. Stump

Erica W. Stump Erica W. Stump, P. A.110 E. Broward Blvd., Suite 1700Fort Lauderdale, FL 33301United States

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated anti-age serums, anti-aging cleanser, anti-aging creams and anti-aging moisturising creams; non-medicated serums, cleaning preparations, creams and moisturizers for use on hair, skin, lips, hands and feet; non-medicated herbal preparations for the care of the skin; the aforesaid goods also, but not exclusively, for anti-ageing and longevity purposes; organic cosmetics; raw materials and auxiliary agents used in the manufacture of spa salts, including but not limited to mineral salts, essential oils, herbal extracts, fragrances, and anti-caking agentsACTIVE—
005Dietary supplements in all dosage forms for longevity, anti-aging, biohacking and general wellness; food supplements; the aforesaid goods also, but not exclusively, for anti-ageing and longevity purposes; nutraceuticals and pharmaceuticals preparations to treat or prevent health conditions, diseases, and disorders related to intestinal permeability, the microbiome, and the gut-brain axis; dietary and food supplements consisting of fungal, herb and microbial materials; dietary and food supplements adapted for medical use; biologically active substances of animal, plant or chemical origin, for use in industry and science, namely, food, dietary and nutritional supplements, therapeutic and pharmaceutical preparations, and medical food, namely amino acids, peptides, nucleotides, organic acids, metabolites and analogues thereof, minerals, vitamins, and preservatives, and combinations thereof; preparations for medical and veterinary purposes, in particular diagnostics, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; dietary supplements, namely vitamins, minerals, herbs, botanics, amino acids, all aforementioned as concentrate, metabolite, constituent or extract; medicinal herbs, medicinal tea; nutritional concentrates or nutritional supplements on the basis of herbs, herbal teas, all for health care purposes; milk ferments for pharmaceutical purposes; reagents for use in diagnostic microbiome tests for medical purposes; microbiome preparations for dietary purposes; pharmaceuticals and natural remedies for use in the treatment of gastrointestinal, metabolic, cardiovascular, neurological, autoimmune, infectious, oncological, psychiatric and other diseases and disorders of the human body and mind; plant and herb extracts for medicinal purposes, other than essential oils; microbiome-based products, namely, therapeutics, prebiotics, probiotics, and nutritional foods; diagnostic kits comprising medical diagnostic reagents and assays that test for the presence of biomarkers to determine overall health and microbiome health; food supplements, including liquid food supplements and food and drink supplements; plant compounds and extracts for use as dietary supplements, other than essential oils; dietary supplement vitamin drinks; organic fermented drinks for health care purposes; plant-based, and herb-based drinks including, chaga mushroom extract and herbs, for medicinal purposes and as nutritional supplementsACTIVE—
029Dairy products and dairy substitutes, namely, cream, yoghurt, cheese, concentrated fermented dairy forms; fermented vegetables; kefir; fermented milk beverages, cultured milk drinks; fermented milk and fermented milk productsACTIVE—
030Processed herbs; kombucha tea; vinegar; flavored vinegar; spices; coffee, teas and cocoa and substitutes therefor; fermented tea; ferments for pastes; fermented herbs; fermented paste made of, namely, herbs, teas, plants, honey, microbial cultures and soilACTIVE—
032Syrups for making non-alcoholic fermented beverages, energy drinks, flavoured waters; non-alcoholic essences for making non-alcoholic beverages, not in the nature of essential oils; non-alcoholic essences for making soft drinks, not in the nature of essential oils; non-alcoholic fruit, herb and plant extracts used in the manufacture of beverages; non-alcoholic water-based, fermented beverages in the nature of water kefir; effervescent beverages, namely, carbonated waters, non-alcoholic carbonated drinks, and soft drinks; refreshment drinks, namely, fruit juice drinks, herbal drinks, tea-based drinks, carbonated soft drinks, flavored waters, isotonic and electrolyte drinks; fruit juices and fruit juice mixtures for making non-alcoholic fruit juice beverages; non-alcoholic malt beverages; hop concentrates, namely, hop flowers for making beers; raw materials and auxiliary agents, namely natural and synthetic ingredients, used in the manufacture of non-alcoholic beverages, including flavorings, colorants, sweeteners, stabilizers, plant-derived metabolites, analogues of plant-derived metabolites, organic acids, minerals, amino acids and their derivatives, peptides and their derivatives, nucleotides, and preservatives; non-alcoholic fermented beverages including nutritionally fortified beverages; dilutable preparations for making non-alcoholic, fermented beverages; concentrates for use in the preparation of soft drinksACTIVE—
042Pharmaceutical drug development services; scientific and technological services, namely, academic and medical research and analysis in the fields of pharmaceutical drug development, companion biomarkers, predictive, preventive and personalized medicine; microbiological testing; genetic research; scientific and industrial analysis research and development services, especially relating to the human and animal microbiome, digestion, intestinal flora and the gastrointestinal microbiome; research, development, in relation to medicine, pharmacy, healthcare preparations, groceries, nutritional aids, dietetic foodstuffs, novel food, functional foods; research and development relating to digestion, intestinal flora and the gastrointestinal microbiomeACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 12, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 25, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 25, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 11, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 11, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 11, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 29, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 11, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 11, 2025RFRRREFUSAL PROCESSED BY MPU—
Jan 24, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 23, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 31, 2024DOCKASSIGNED TO EXAMINER—
Oct 2, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 2, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 26, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance